Welcome to our dedicated page for Seacoast Bkg Fla SEC filings (Ticker: SBCF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Seacoast Banking Corporation of Florida filings document the regulatory record of a Florida bank holding company whose principal operating subsidiary is Seacoast National Bank. Its 8-K reports furnish quarterly and annual results, investor presentations, Regulation FD materials, securities-portfolio actions and other material events tied to bank earnings, deposits, net interest income, capital and liquidity.
Proxy and governance filings describe annual meeting matters, board composition, director elections, compensation and shareholder voting items. Transaction and capital-structure disclosures document completed bank acquisitions, amendments related to Series A Non-Voting Preferred Stock, rights of security holders and other matters affecting Seacoast's common and preferred equity.
An affiliate of the issuer has filed a notice of proposed sale under Rule 144 covering 2,279 shares of common stock. The shares are planned to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ, with an approximate sale date of 02/03/2026 and an aggregate market value of $76,426.27. These shares were acquired the same day via a stock option exercise paid in cash. The issuer had 97,828,149 shares of this class outstanding.
A holder of SBCF common stock filed a notice of proposed sale under Rule 144 for 3,419 shares, with an aggregate market value of $117,032.71. The sale is planned through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ, with an approximate sale date of February 3, 2026.
The shares to be sold were acquired on February 3, 2026 by exercising a stock option and paying the purchase price in cash. The filing lists 97,828,149 common shares outstanding, providing context for the relative size of this planned sale.
Seacoast Banking Corporation of Florida reported year-end 2025 results and described a significant investment portfolio move. The company sold available-for-sale securities with an average book yield of 1.9%, realizing a pre-tax loss of about $39.5 million, and reinvested roughly $277 million of proceeds into primarily agency mortgage-backed securities yielding 4.8% on a taxable equivalent basis.
Seacoast is also holding an investor conference call to discuss its quarter and year ended December 31, 2025, supported by presentation materials made available on its website.
Seacoast Banking Corporation of Florida director H. Gilbert Culbreth Jr. reported receiving 454 shares of common stock on 01/15/2026 at a price of $33.84 per share. After this acquisition, he directly beneficially owned 47,954.87 shares, including amounts held in Seacoast's Non-employee Directors Deferred Compensation Plan, an IRA, and accounts held jointly with his spouse, daughter, and son. He also reported 26,000 shares held through a family limited liability company and 8,200 shares held through a family sub-S corporation, which are classified as indirect ownership. In addition, he holds a right to buy 2,142 shares of common stock at an exercise price of $22.65, which is exercisable from 02/06/2017 until 02/05/2027 under Seacoast Banking Corporation of Florida's 2013 Incentive Plan.
Seacoast Banking Corp. of Florida (SBCF) director Christopher E. Fogal reported an option exercise and share acquisition. On 11/19/2025, he exercised a right to buy 3,419 shares of common stock at $14.39 per share, coded as transaction type “M” (exercise of derivative security). Following this transaction, he directly owns 14,780 shares of Seacoast common stock.
In addition to his direct holdings, he reports 31,966.76 shares held in Seacoast’s Non-employee Directors Deferred Compensation Plan, 6,875 shares held jointly with his spouse, and 4,688 shares held indirectly in a trust for his spouse. He also retains outstanding stock options with exercise prices of $22.65, $27.53, and $28.42 covering 2,142, 1,431, and 1,146 shares, respectively.
Seacoast Banking Corp. of Florida (SBCF) director reported an open‑market sale of 8,000 common shares on 11/10/2025 at a weighted average price of $31.13.
Following the sale, the reporting person beneficially owned 251,275 common shares directly (held in trust), with additional holdings including 18,104 directly (joint with spouse), 33,632.343 in the company retirement plan as of June 30, 2025, and 9,356 in an IRA, plus indirect positions held by spouse in trust and a family partnership.
Derivative positions include rights to buy 55,279 shares at $31.15 expiring 04/02/2028 and 78,021 shares at $28.69 expiring 04/03/2027.
Seacoast Banking Corp. of Florida (SBCF): Form 4 insider transaction. EVP and Chief Credit Officer James C. Stallings, III sold 3,245 shares of common stock on 11/05/2025 at $30.87 per share. Following the sale, he directly owned 3,727 shares.
He also holds unvested time‑based restricted stock awards: 3,431 shares granted on April 1, 2025 (vesting in one‑third increments beginning April 1, 2026), 7,185 shares granted on April 1, 2024 (vesting beginning April 1, 2025), and 1,260 shares granted on April 1, 2023 (vesting beginning April 1, 2024), each subject to continued employment.
Seacoast Banking Corporation of Florida furnished an investor presentation and announced plans to hold one‑on‑one investor meetings in November 2025. The presentation, attached as Exhibit 99.1 and available at www.seacoastbanking.com, outlines the company’s business strategy, financial performance, recent developments, and future opportunities.
The materials are provided under Item 7.01 (Regulation FD) and are deemed “furnished,” not “filed,” which limits their use under the Exchange Act. Information is presented as of the dates indicated, and the company does not assume an obligation to update it.
Seacoast Banking Corporation of Florida (SBCF) reported third‑quarter results. Net income was $36.5M, up from $30.7M a year ago, and diluted EPS was $0.42 versus $0.36. Net interest income rose to $133.5M from $106.7M as loan interest and securities income increased while deposit costs eased year over year.
Provision for credit losses was $8.4M (vs. $6.3M). Noninterest income was $23.8M, roughly flat, while noninterest expense increased to $102.0M, including $10.8M of merger‑related charges. Comprehensive income benefited from higher unrealized gains in AFS securities.
On the balance sheet, total assets reached $16.68B with loans at $10.96B and deposits at $13.09B. AFS securities were $3.21B. FHLB borrowings were $690.0M. The company issued shares for acquisitions during the period, and equity rose to $2.38B with accumulated other comprehensive loss improving.
Seacoast Banking Corporation of Florida announced its financial results for the quarter ended September 30, 2025. The company will host an investor conference call on October 28, 2025 to discuss the quarter. Related materials were furnished as Exhibits 99.1 (press release) and 99.2 (presentation) and are incorporated by reference. The disclosures are provided under Items 2.02 and 7.01 of an 8-K and are furnished, not filed.